Chargement en cours...
Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study
BACKGROUND: In October 2017, the United Kingdom Joint Committee on Vaccination and Immunisation (JCVI) recommended removal of one primary dose of the 13-valent pneumococcal conjugate vaccine (PCV13) from the existing 2+1 schedule (2, 4, 12 months). We conducted a mathematical modelling study to inve...
Enregistré dans:
| Publié dans: | PLoS Med |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608946/ https://ncbi.nlm.nih.gov/pubmed/31269018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002845 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|